Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES. (Q42801736)

7 November 2017

Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES. (English)

1 reference

experimental autoimmune encephalomyelitis

7 November 2017

1 reference

Jia Y

1

1 reference

7 November 2017

Li H

2

1 reference

7 November 2017

Chen W

3

1 reference

7 November 2017

Li M

4

1 reference

7 November 2017

Lv M

5

1 reference

7 November 2017

Feng P

6

1 reference

7 November 2017

Hu H

7

1 reference

7 November 2017

Zhang L

8

1 reference

7 November 2017

18 May 2006

1 reference

7 November 2017

1 reference

7 November 2017

13

1 reference

7 November 2017

1351-1359

1 reference

7 November 2017

18

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302799

7 November 2017

0 references

cites work

A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Magnetic resonance imaging of PLP-induced experimental allergic encephalomyelitis in Lewis rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Gene therapy in autoimmune, demyelinating disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Gene therapy in a murine model for clinical application to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

Normal T-helper 1/T-helper 2 balance in peripheral blood of coeliac disease patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302799

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302799

1 reference

Dimensions Publication ID

7 November 2017

0 references

1 reference